Advertisement
U.S. markets open in 3 hours 52 minutes
  • S&P Futures

    5,209.00
    -5.75 (-0.11%)
     
  • Dow Futures

    39,183.00
    -40.00 (-0.10%)
     
  • Nasdaq Futures

    18,209.75
    -21.75 (-0.12%)
     
  • Russell 2000 Futures

    2,042.50
    -7.30 (-0.36%)
     
  • Crude Oil

    82.52
    -0.20 (-0.24%)
     
  • Gold

    2,154.70
    -9.60 (-0.44%)
     
  • Silver

    25.08
    -0.19 (-0.75%)
     
  • EUR/USD

    1.0848
    -0.0028 (-0.26%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.52
    +0.19 (+1.33%)
     
  • GBP/USD

    1.2679
    -0.0050 (-0.39%)
     
  • USD/JPY

    150.5630
    +1.4650 (+0.98%)
     
  • Bitcoin USD

    63,825.32
    -4,322.90 (-6.34%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,717.49
    -5.06 (-0.07%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

At UK£11.10, Is Treatt plc (LON:TET) Worth Looking At Closely?

Treatt plc (LON:TET), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the past couple of months on the LSE. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, what if the stock is still a bargain? Today I will analyse the most recent data on Treatt’s outlook and valuation to see if the opportunity still exists.

View our latest analysis for Treatt

What is Treatt worth?

According to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average, the stock currently looks expensive. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Treatt’s ratio of 48.57x is above its peer average of 24.9x, which suggests the stock is trading at a higher price compared to the Chemicals industry. Furthermore, Treatt’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach levels around its industry peers, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

What kind of growth will Treatt generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 42% over the next couple of years, the future seems bright for Treatt. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? TET’s optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question – should I sell? If you believe TET should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping an eye on TET for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for TET, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. At Simply Wall St, we found 1 warning sign for Treatt and we think they deserve your attention.

If you are no longer interested in Treatt, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Advertisement